# Phase I Platinum Based Chemotherapy Plus Indomethacin

> **NCT01719926** · PHASE1 · COMPLETED · sponsor: **UMC Utrecht** · enrollment: 13 (actual)

## Conditions studied

- Colorectal Neoplasms
- Esophageal Neoplasms
- Ovarian Neoplasms

## Interventions

- **DRUG:** Indomethacin

## Key facts

- **NCT ID:** NCT01719926
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2017-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01719926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01719926, "Phase I Platinum Based Chemotherapy Plus Indomethacin". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01719926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*